Psilocybin, the active compound found in magic mushrooms, organizes brain networks into a structured pattern rather than merely scrambling neural activity, according to a five-year study.
Brain Scans Reveal Hidden Order Amid Neural Disruption
Previous research established that psychedelics disrupt standard brain network organization, effectively blurring boundaries between regions responsible for processing internal thoughts and the external world. "We have discovered a hidden order amidst this disruption," Stoliker stated regarding the brain's response to the substance.
Context and Environment Shape Brain Patterns
The study demonstrated that neural organization shifts dynamically depending on the immediate environment and the focus of the participant. Brain patterns varied significantly whether participants were resting, listening to music, meditating, or watching a film, according to senior author and study leader Adeel Razi. “This illustrates that context is not merely a backdrop for the psychedelic experience,” Razi noted, adding that what a person does and where they direct their attention shapes the neurological reaction.
Pro Tip: For clinical and therapeutic applications, researchers emphasize that the physical environment, patient actions, and experiences during a session play a critical role in determining neurological outcomes.
Therapeutic Implications for Depression and Chronic Pain
Medical interest in psilocybin has grown alongside broader investigations into the therapeutic use of controlled substances for treatment-resistant depression and chronic pain. Australia granted regulatory approval for medical psilocybin use in 2023, drawing considerable public debate. Following Australia’s decision, Czechia followed suit in 2026, while a growing number of international jurisdictions monitor clinical outcomes to evaluate potential policy updates.
Did you know? Researchers at the University of Melbourne utilized data from 62 participants across various sensory and resting environments to map how individual neural responses can be measured for future clinical diagnostics.
Clinicians may eventually use these individual neural response measurements to assess how patients respond to specific treatments and to predict which individuals will benefit most from psychedelic therapy, according to Razi.
Frequently Asked Questions
What does psilocybin do to the brain according to recent research?
Which countries have approved psilocybin for medical use?
Australia approved psilocybin for treating treatment-resistant depression in 2023, followed by Czechia in 2026.
Does the environment affect a person’s neurological response to psilocybin?
Yes. According to study leader Adeel Razi, neural patterns change depending on whether a person is resting, listening to music, meditating, or watching a film, proving that the immediate context shapes the brain’s reaction.
Explore More: Keep up with the latest developments in medical research and mental health therapies by exploring our related coverage on clinical trials and pain management innovations. Subscribe to our weekly newsletter for updates straight to your inbox.